Population Pharmacokinetics of Ruxolitinib in Patients with aGVHD Who Had an Inadequate Response to Corticosteroids

鲁索利替尼 医学 骨髓纤维化 人口 内科学 队列 骨髓 环境卫生
作者
Xuejun Chen,Xiang Liu,Phillip Wang,Swamy Yeleswaram
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 4534-4534 被引量:2
标识
DOI:10.1182/blood-2019-124027
摘要

Background: Jakafi® (ruxolitinib) is currently approved for the treatment of adult patients with intermediate- and high-risk myelofibrosis (MF) and for the treatment of adult patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant to hydroxyurea. A prospective, open-label, single-cohort, Phase 2 study (REACH1) was conducted to evaluate the safety and efficacy of Jakafi® (ruxolitinib) in patients with acute graft versus host disease (aGVHD) who have had an inadequate response to corticosteroids. A population PK analysis was employed to characterize the PK of ruxolitinib in this patient population. Patients and Methods: REACH1, Study INCB 18424-251, and COMFORT-I are the 3 studies supporting the population PK of ruxolitinib; the first study is in participants with aGVHD who have had an inadequate response to corticosteroids, and the other 2 studies are in participants with MF. First, the final PK model for ruxolitinib in patients with MF was applied to the data in patients with MF and aGVHD. When significant biases were observed in this validation process, new population PK models were developed based on the pooled data. The accuracy and robustness of the final population PK model were assessed using a predictive check method. Results: An under-prediction bias was observed at the population level when existing PK model in MF was applied to pooled data in patients with MF and aGVHD. A new model was developed to account for the under prediction bias at the population level. The final population PK model for ruxolitinib was a 2 compartment disposition model with first order absorption, absorption lag time, and linear elimination. Body weight and gender were significant predictors of the volume of distribution of the central compartment and oral clearance, respectively. Patients with aGVHD showed lower oral clearance (66.7%) and slower rate of absorption (~28%) than that in patients with MF. The stage of liver involvement in GVHD and use of moderate or potent CYP3A4 inhibitors were identified as covariates for ruxolitinib CL. Conclusion: The population PK analysis supports the proposed dose regimen in patients with aGVHD who had an inadequate response to corticosteroids as well as dose recommendations for DDI and subjects with organ dysfunction. Disclosures Chen: Incyte Research Institute: Employment. Liu:Incyte Research Institute: Employment. Wang:Incyte Research Institute: Employment. Yeleswaram:Incyte Research Institute: Employment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大勺完成签到 ,获得积分10
刚刚
科研狗敏敏完成签到,获得积分20
1秒前
牛马完成签到 ,获得积分10
1秒前
4秒前
普鲁卡因完成签到,获得积分10
5秒前
倪塔宝贝完成签到 ,获得积分10
5秒前
小花生完成签到 ,获得积分10
5秒前
知了完成签到 ,获得积分10
9秒前
为你钟情完成签到 ,获得积分10
10秒前
13秒前
14秒前
韭菜盒子发布了新的文献求助10
16秒前
潘特发布了新的文献求助10
19秒前
乌滴子完成签到,获得积分10
20秒前
量子星尘发布了新的文献求助10
21秒前
善学以致用应助韭菜盒子采纳,获得10
21秒前
jiaaniu完成签到 ,获得积分10
23秒前
清脆靳完成签到,获得积分10
24秒前
cp3xzh完成签到,获得积分10
24秒前
tian发布了新的文献求助10
26秒前
tian发布了新的文献求助10
26秒前
明理宛秋完成签到 ,获得积分10
27秒前
S月小小完成签到,获得积分10
31秒前
斯文的慕儿完成签到 ,获得积分10
38秒前
keen完成签到 ,获得积分10
38秒前
韭菜盒子完成签到,获得积分20
39秒前
潘特完成签到,获得积分10
40秒前
小彭友完成签到,获得积分10
51秒前
52秒前
josie完成签到 ,获得积分10
56秒前
llll完成签到 ,获得积分10
56秒前
量子星尘发布了新的文献求助10
56秒前
韭菜发布了新的文献求助10
56秒前
外向的斑马完成签到 ,获得积分10
57秒前
村长热爱美丽完成签到 ,获得积分10
59秒前
尹尹关注了科研通微信公众号
1分钟前
呆呆完成签到 ,获得积分10
1分钟前
xianyaoz完成签到 ,获得积分0
1分钟前
杨远杰完成签到,获得积分10
1分钟前
蓝桉完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022